Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 145

1.

Recovery of infectious Ebola virus from complementary DNA: RNA editing of the GP gene and viral cytotoxicity.

Volchkov VE, Volchkova VA, Muhlberger E, Kolesnikova LV, Weik M, Dolnik O, Klenk HD.

Science. 2001 Mar 9;291(5510):1965-9. Epub 2001 Feb 1.

2.

GP mRNA of Ebola virus is edited by the Ebola virus polymerase and by T7 and vaccinia virus polymerases.

Volchkov VE, Becker S, Volchkova VA, Ternovoj VA, Kotov AN, Netesov SV, Klenk HD.

Virology. 1995 Dec 20;214(2):421-30.

3.

RNA Editing of the GP Gene of Ebola Virus is an Important Pathogenicity Factor.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S226-33. doi: 10.1093/infdis/jiv309. Epub 2015 Jul 2.

PMID:
26138826
4.

The nonstructural small glycoprotein sGP of Ebola virus is secreted as an antiparallel-orientated homodimer.

Volchkova VA, Feldmann H, Klenk HD, Volchkov VE.

Virology. 1998 Oct 25;250(2):408-14.

5.

Identification of the Ebola virus glycoprotein as the main viral determinant of vascular cell cytotoxicity and injury.

Yang ZY, Duckers HJ, Sullivan NJ, Sanchez A, Nabel EG, Nabel GJ.

Nat Med. 2000 Aug;6(8):886-9.

PMID:
10932225
6.

Genomic RNA editing and its impact on Ebola virus adaptation during serial passages in cell culture and infection of guinea pigs.

Volchkova VA, Dolnik O, Martinez MJ, Reynard O, Volchkov VE.

J Infect Dis. 2011 Nov;204 Suppl 3:S941-6. doi: 10.1093/infdis/jir321.

PMID:
21987773
7.

Molecular characterization of guinea pig-adapted variants of Ebola virus.

Volchkov VE, Chepurnov AA, Volchkova VA, Ternovoj VA, Klenk HD.

Virology. 2000 Nov 10;277(1):147-55.

8.

Ebola sGP--the first viral glycoprotein shown to be C-mannosylated.

Falzarano D, Krokhin O, Van Domselaar G, Wolf K, Seebach J, Schnittler HJ, Feldmann H.

Virology. 2007 Nov 10;368(1):83-90. Epub 2007 Jul 20.

9.

Release of viral glycoproteins during Ebola virus infection.

Volchkov VE, Volchkova VA, Slenczka W, Klenk HD, Feldmann H.

Virology. 1998 May 25;245(1):110-9.

10.

Ebola Virus GP Gene Polyadenylation Versus RNA Editing.

Volchkova VA, Vorac J, Repiquet-Paire L, Lawrence P, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S191-8. doi: 10.1093/infdis/jiv150. Epub 2015 Apr 2.

PMID:
25838269
11.

A new Ebola virus nonstructural glycoprotein expressed through RNA editing.

Mehedi M, Falzarano D, Seebach J, Hu X, Carpenter MS, Schnittler HJ, Feldmann H.

J Virol. 2011 Jun;85(11):5406-14. doi: 10.1128/JVI.02190-10. Epub 2011 Mar 16.

12.

Cyanovirin-N binds to the viral surface glycoprotein, GP1,2 and inhibits infectivity of Ebola virus.

Barrientos LG, O'Keefe BR, Bray M, Sanchez A, Gronenborn AM, Boyd MR.

Antiviral Res. 2003 Mar;58(1):47-56.

PMID:
12719006
13.

The glycoproteins of Marburg and Ebola virus and their potential roles in pathogenesis.

Feldmann H, Volchkov VE, Volchkova VA, Klenk HD.

Arch Virol Suppl. 1999;15:159-69. Review.

PMID:
10470276
14.

Downregulation of beta1 integrins by Ebola virus glycoprotein: implication for virus entry.

Takada A, Watanabe S, Ito H, Okazaki K, Kida H, Kawaoka Y.

Virology. 2000 Dec 5;278(1):20-6.

15.

Ebola virus glycoprotein GP is not cytotoxic when expressed constitutively at a moderate level.

Alazard-Dany N, Volchkova V, Reynard O, Carbonnelle C, Dolnik O, Ottmann M, Khromykh A, Volchkov VE.

J Gen Virol. 2006 May;87(Pt 5):1247-57.

PMID:
16603527
16.
17.

Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.

Usami K, Matsuno K, Igarashi M, Denda-Nagai K, Takada A, Irimura T.

Biochem Biophys Res Commun. 2011 Apr 1;407(1):74-8. doi: 10.1016/j.bbrc.2011.02.110. Epub 2011 Mar 6.

PMID:
21362405
18.

Detection and molecular characterization of Ebola viruses causing disease in human and nonhuman primates.

Sanchez A, Ksiazek TG, Rollin PE, Miranda ME, Trappier SG, Khan AS, Peters CJ, Nichol ST.

J Infect Dis. 1999 Feb;179 Suppl 1:S164-9.

PMID:
9988180
19.

Modulation of virion incorporation of Ebolavirus glycoprotein: effects on attachment, cellular entry and neutralization.

Marzi A, Wegele A, Pöhlmann S.

Virology. 2006 Sep 1;352(2):345-56. Epub 2006 Jun 13.

20.

Shedding of Ebola Virus Surface Glycoprotein Is a Mechanism of Self-regulation of Cellular Cytotoxicity and Has a Direct Effect on Virus Infectivity.

Dolnik O, Volchkova VA, Escudero-Perez B, Lawrence P, Klenk HD, Volchkov VE.

J Infect Dis. 2015 Oct 1;212 Suppl 2:S322-8. doi: 10.1093/infdis/jiv268. Epub 2015 Jun 19.

PMID:
26092855

Supplemental Content

Support Center